HD-OPM Archive
Topics › Hormones, women's & men's health

No credible RCT shows TRT extends life or lowers disease risk in men without hypogonadism

Louis Nervegna · Jul 12, 2025 · ♥ 7 reactions · 0 comments · original Facebook post
Hormones, women's & men's healthAging & longevity
AI summary & key facts

Louis argues no randomized trial has shown testosterone therapy lowers disease risk or extends lifespan in men without clinical hypogonadism, some studies show harm, and animal experiments show raised testosterone shortens lifespan. He cites a Scientific American feature on testosterone therapy risks.

No credible randomized controlled trial in humans has ever shown that TRT lowers risk for any disease or extends lifespan in men without clinically diagnosed hypogonadism. Some studies have shown evidence of harm.

Reference:
↪ Testosterone for anti-aging lacks proven longevity benefit; high levels tied to deaths

And here is the dark truth that these TRT clinics will not tell you:

In animal experiments— including primates and other mammals like rodents— raising testosterone consistently shortens lifespan. See the reference linked-to above.

Quoted:

“Testosterone is a very robust indicator of general health status,” Wu says. “If you find low T in a patient, then it is imperative to investigate their general health status rather than having a knee-jerk reaction of starting testosterone treatment.”

#testosteroneHD #trtHD #agingHD #longevityHD

Research cited

To boost mood and manliness, men are spending lots of money on the hormone testosterone—yet they may see trouble instead of benefits. Learn more in our July/August 2025 Issue!

← newer: Testosterone has no proven longevity benefit beyond treatingolder: US cardiovascular death decline since the 1960s has stalled →